PepGen
The Associate Director, Statistical Programming will lead statistical programming efforts for PepGen's clinical programs, overseeing CRO and external vendor deliverables, ensuring data quality and regulatory compliance, and contributing to the development of programming standards and processes. This role serves as a technical subject‑matter expert within the Biometrics function, collaborating with cross‑functional teams and external partners.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2018
PepGen is a clinical-stage biotechnology company developing peptide-enabled oligonucleotide therapeutics to treat serious genetic neuromuscular and neurological diseases. Their proprietary Enhanced Delivery Oligonucleotide (EDO) platform is designed to improve cellular uptake and tissue targeting of genetic therapies, with programs targeting conditions such as Duchenne muscular dystrophy and myotonic dystrophy. PepGen advances its pipeline through preclinical and clinical development, combining peptide chemistry and nucleic-acid expertise to address the root causes of debilitating genetic diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for PepGen.
12% below the average for this role